BIOENHANCED FORMULATIONS COMPRISING EPROSARTAN IN ORAL SOLID DOSAGE FORM

摘要

This invention relates to bioenhanced formulations comprising eprosartan oreprosartan mesylate in the amorphous form, a processfor its production, compositions containing the compound and methods of usingthe compound to block angiotensin II receptors and to treathypertension, congestive heart failure and renal failure.